about
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityEmerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control studyBench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useStatistical metamodeling for revealing synergistic antimicrobial interactionsDecreasing antibiotic overuse in neonatal intensive care units: quality improvement research.Antibiotic stewardship in the intensive care unit.Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004Use of longitudinal surveillance data to assess the effectiveness of infection control in critical care.Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatmentAppraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.Antimicrobial consumption and impact of "Reserve antibiotic indent form" in an intensive care unit.Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitalsImplications of stress-induced genetic variation for minimizing multidrug resistance in bacteriaRapid optical determination of β-lactamase and antibiotic activityAntibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use.Antimicrobial Use and Resistance.Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units.Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial.Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia.Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients.Combination therapy for treatment of infections with gram-negative bacteria.Empirical antibiotic therapy for pneumonia in intensive care units: a multicentre, retrospective analysis of potentially pathogenic microorganisms identified by endotracheal aspirates cultures.Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-AnalysisHow to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.Quantitative PCR for Etiologic Diagnosis of Methicillin-Resistant Staphylococcus aureus Pneumonia in Intensive Care UnitHemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies.Changes in gram negative microorganisms' resistance pattern during 4 years period in a referral teaching hospital; a surveillance studyPrevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations.Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.Pharmacology of novel heteroaromatic polycycle antibacterials.Rapid identification of antibiotic resistance using droplet microfluidics.Management of ventilator-associated pneumonia in intensive care units: a mixed methods study assessing barriers and facilitators to guideline adherence.Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trialEpidemiologically relevant antimicrobial resistance phenotypes in pathogens isolated from critically ill patients in a Brazilian Universitary HospitalIncidence and outcome of sepsis in Japanese intensive care units: The Japanese nosocomial infection surveillance system.
P2860
Q24530412-CCD9D24F-28C6-4244-B75C-2CA28FCA4D2AQ24798403-80E410F6-C44C-46E4-A8F5-C4428ACFA22BQ24811686-6160E6B8-3E1B-423E-9170-3FDB5EF26D1EQ24813204-638E6347-9291-44A1-A9E7-E26D4337025BQ28299749-1A9885D4-47DB-429A-B489-4CB1D3D6F6DBQ28476193-CDD47593-EF3B-44CF-BB05-294404792954Q28769501-3FE01909-A231-4182-AFB0-39264E125B8DQ30408712-CE811032-90DC-44FE-B8C0-7C9375B7AA2CQ31087017-3916F19B-964B-429A-88C1-E1E436B53745Q33508663-3E46C0AA-DCAE-4092-8B6B-FA8B03BB7817Q33722082-EAC4753F-2B01-425C-B11B-499AB8DA66AEQ34003193-422E93C3-6D5F-46C3-A349-A2CF1BDC8C78Q34222844-3B081E1B-11AE-4BE8-BC4D-1CB29FC1F455Q34340879-EDD7993F-78C7-4DB2-9C0F-15277FD2DC7CQ34378318-2EEFDD85-911F-43A9-9573-A43E704D9DC0Q34523982-77A9EAF3-1ADA-4BEE-B8C5-406971578D61Q34908030-AC2FA802-7960-478B-895C-2D7F68137E50Q34998303-2542D415-9660-400E-A6A9-9904298E281FQ35567200-A7B96D84-1F25-4524-91EA-707C1A5769A6Q35595002-9BAE4150-F699-4D7E-90E7-8E39B83F84A2Q35685688-EAB913C6-72E0-4B96-92F7-C400C1EB21C6Q36048603-C921F4E2-418F-41F7-AC87-CBCDC5A1B80BQ36156077-88076F61-80C1-4879-9B87-128703E40AA2Q36167408-AA296F9C-610A-47FE-ABCD-1B4FC4E14397Q36219506-41343208-DD70-4C4F-A899-D5D0FC8B884AQ36231431-5BE768F4-E841-43B1-BC49-76D69FF34276Q36275612-C6762184-2970-4AF0-8F82-1A711E773429Q36434283-6CCCD019-89EE-4A81-BF7D-C8DF8F4FCBFEQ36498293-0C0B5D6D-11E3-4437-980D-6C81806CA92FQ36564502-DD84043F-4717-4FB0-9B56-578F769BF3BFQ36712272-07F7300C-3685-4184-A7A2-9EAD203BC6F3Q36735014-C85BF2DD-E815-4062-A2AA-CF70C52ED1F8Q36844767-8853DC82-9A33-4230-8572-7C92945A6B5AQ36864125-20D98C0A-9592-49CD-9392-337B43DE23EDQ36879860-5378127F-A769-41D2-98B9-8085DB76DBA9Q36935009-99242B39-4982-4D23-8858-37682876EC56Q37118261-D3C7BABF-4527-4941-94AB-8B18DAF68C4DQ37145742-91B04C04-A812-42DE-8544-180A4A110503Q37159254-0CEE7778-9D10-4BBE-80D1-2A36A65B4EA4Q37296259-164669C6-D7D5-4F35-9A9E-483AE90081A8
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antibiotic resistance in the intensive care unit.
@ast
Antibiotic resistance in the intensive care unit.
@en
Antibiotic resistance in the intensive care unit.
@nl
type
label
Antibiotic resistance in the intensive care unit.
@ast
Antibiotic resistance in the intensive care unit.
@en
Antibiotic resistance in the intensive care unit.
@nl
prefLabel
Antibiotic resistance in the intensive care unit.
@ast
Antibiotic resistance in the intensive care unit.
@en
Antibiotic resistance in the intensive care unit.
@nl
P1476
Antibiotic resistance in the intensive care unit.
@en
P2093
P304
P356
10.7326/0003-4819-134-4-200102200-00014
P407
P577
2001-02-01T00:00:00Z